Skip to content

3D Visualization System in Highly Myopic Cataract Operation

Comparing the Effect of Depth of Focus Difference in High Myopic Patients Receiving Cataract Operations Between 3D Visualization System and Traditional Optical Microscope.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06264830
Acronym
3D-HiMCO
Enrollment
40
Registered
2024-02-20
Start date
2024-07-03
Completion date
2025-12-31
Last updated
2026-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract, High Myopia

Keywords

Cataract, High Myopia, Digital 3D System, Depth of Field

Brief summary

This study aims to investigate the impact of depth of field differences between the use of the 3D imaging system (NGENUITY® 3D Visualization System, Alcon, TX, USA) and conventional optical microscope in cataract surgery for highly myopic patients on intraoperative parameters and outcomes.

Detailed description

The objective of this study is to compare the surgical outcomes and parameters between cataract surgeries performed using the NGENUITY® 3D Visualization System (Alcon, TX, USA), a 3D imaging system, and the current standard binocular microscope in highly myopic patients. The focus is on evaluating the differences in depth of field and their impact on intraoperative parameters and outcomes. This prospective randomized controlled trial aims to enroll patients with both high myopia and cataracts requiring surgical intervention. Participants will be randomly assigned to undergo cataract surgery using the current standard binocular microscope (control group) or the NGENUITY® 3D Visualization System (Alcon, TX, USA) (study group). The study will compare intraoperative parameters, surgical outcomes, and the incidence of potential complications, including the frequency of microscope adjustments during surgery, total distance of adjustments during surgery, distance needed to achieve clear focus from the corneal surface to the posterior capsule, surgical duration, cumulative ultrasound energy during surgery, and occurrence of surgical complications.

Interventions

DEVICEAlcon-NGENUITY®(NG)-system

During operation, the Alcon NGENUITY® (NG) System is mounted on microscope, while the surgeon will wear 3D glasses, watch 3D screen, and perform operation

PROCEDUREStandard cataract operation

Standard, modern cataract extraction with standard phacoemulsification technique, and posterior chamber intraocular lens implantation.

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER
Alcon Research
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. High myopia (axial length of 26 millimeters or more). 2. Presence of clinically significant age-related nuclear cataract requiring surgery, assessed using the International Classification System for Cataract (Lens Opacities Classification System III, LOC III), with a graded score indicating nuclear cataract (LOC III NC/NO grade 3-5). 3. Participants must be 20 years of age or older.

Exclusion criteria

1. The target eye has undergone vitrectomy surgery. 2. The target eye has undergone corneal refractive surgery. 3. Presence of corneal diseases such as corneal dystrophy, corneal trauma, corneal scarring, corneal ulcers, or clinically significant corneal softening that significantly affects the clarity of cataract surgery. 4. Complicated cataracts with features such as extreme hardness, complex composition, zonular laxity, lens dislocation, extensive capsular fibrosis, or those falling under the international cataract classification standards LOCIII NO/NC6 or C4-C5 or P4-P5. 5. Presence of other non-myopia-related eye diseases significantly affecting the complexity of surgery, such as adhesive uveitis causing adhesions, corneal damage due to trauma or lens dislocation, structural changes and adhesions due to intraocular inflammation, or severe uncorrected strabismus affecting eye alignment.

Design outcomes

Primary

MeasureTime frameDescription
Number of times of Microscopic focus adjustment, measured by counting from the video recordingsThroughout operationA video recorder will focus on the sliding joint between main suspension arm of microscope and its lens system. Once the surgeon change the focus, the marks on both side of the joint will change their relative positions. The times of changes will be counted from the video recording.

Secondary

MeasureTime frameDescription
Distance of subjective focus change in millimeter between corneal surface and surface of posterior capsule, measured by ruler set on microscopeDuring the operation, immediately after lens material is removed, and immediately before the intraocular lens is implanted.On the microscope one ruler will place on the suspension arm of microscope just beside the sliding joint of main optic lens system. On the side of main optic lens system, there will be a mark. When the surgeon change the focus of the microscope. The mark will change its position relative to the ruler with millimeter in scale. Distance in millimeter of subjective focus between corneal surface and surface of posterior capsule can thus be measured.
Total moving distance in millimeter of microscope-lens-system relative to suspension arm, measured by ruler set on microscopeThroughout operationOn the microscope one ruler will place on the suspension arm of microscope just beside the sliding joint of main optic lens system. On the side of main optic lens system, there will be a mark. When the surgeon change the focus of microscope. The mark will change its position relative to the ruler with millimeter in scale. The total moving distance is the add-ups of all changes during operation in absolute value.
Total operation timeThroughout operationTotal operation time
Cumulative dissipated energy (CDE) of phacoemulsification, that is automatically measured and demonstrated on the screen of phacoemulsification machine (Centurion)Throughout operationCumulative dissipated energy (CDE) is defined as mean phaco power times phaco time. CDE will be automatically measured and calculated by the Alcon centurion phacoemulsification machine, and will be demonstrated on the screen of the machine. CDE is itself the unit. The lower the CDE for an operation, the better.
Number of Participants with intraoperative complicationThroughout operationNumber of Participants with intraoperative complication
Best-corrected visual acuity of the operated eye of Participants at each postoperative follow-up within 3 month, measured with Snellen chart under standard condition (6 meters in distance and standard illumination of environment)Within 3 month after operation, at postoperative day1, at postoperative week 1, at post operative month 1, at post operative month 3The best-corrected visual acuity (BCVA) measured with Snellen chart is expected to range from 20/20(1.0) to 20/400(0.05). The refraction of the eye will be carefully corrected using trial lens. The higher the Snellen-chart value, and better the vision. For worse vison. The BCVA will be documented with able to count finger at certain distance ( such as100 centimeter or 30 centimeter). For even worse one, the BCVA will be documented with able to tell hand waving or not at certain distance ( such as100 centimeter or 30 centimeter). For even worse one, the BCVA will be documented with light perception or no light perception.
Number of Participants with post-operative complicationWithin three month after operation, at postoperative day1, at postoperative week 1, at post operative month 1, at post operative month 3Number of Participants with post-operative complication
Intraocular pressure of the operated eye of participants at each postoperative follow-up within 3 month, measured with pneumatic tonometerWithin 3 month after operation, at postoperative day1, at postoperative week 1, at post operative month 1, at post operative month 3The intraocular pressure will be measured with pneumatic tonometer

Countries

Taiwan

Contacts

PRINCIPAL_INVESTIGATORTzyy-Chang Ho

National Taiwan University Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 20, 2026